Clinical Trials Directory

Trials / Completed

CompletedNCT01771939

Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes

Morphologic and Functional Results After Phacoemulsification and 25 Gauge Vitrectomy Versus Phacoemulsification Only in Eyes Affected by Idiopathic Epiretinal Membranes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Turin, Italy · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the difference in Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, oct retinal thickness and microperimetry in 2 groups of 30 eyes each affected by idiopathic epiretinal membranes that underwent phacoemulsification and 25G pars-plana vitrectomy with internal limiting membrane (ILM) peeling (Group 1) versus phacoemulsification only (Group 2), with a follow-up length up to 5 years.

Detailed description

Idiopathic epiretinal membranes represent a common cause of visual loss in elderly population. Vitrectomy with membrane peeling is nowadays considered the gold standard in the management of such pathology, with very good results either at short-time or at long-time follow up. In case of mild visual impairment due to epiretinal membrane and associated cataract, it is reasonable to treat only the lens pathology (with phacoemulsification and intra-ocular lens (IOL) implantation). In case of symptoms or ophthalmoscopic finding worsening it is always possible to submit patients who only underwent cataract surgery to vitrectomy with membrane peeling. There are, by now, no comparative studies between these two different approaches in medical literature.

Conditions

Interventions

TypeNameDescription
PROCEDURE25-G vitrectomy and phacoemulsification25-G vitrectomy with Internal Limiting Membrane peeling and phacoemulsification (cataract intervention)
PROCEDUREphacoemulsification (cataract surgery)lens extraction after phacoemulsification and intra-ocular artificial lens implantation

Timeline

Start date
2006-10-01
Primary completion
2006-11-01
Completion
2012-07-01
First posted
2013-01-18
Last updated
2013-01-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01771939. Inclusion in this directory is not an endorsement.